Leo Phar­ma of­floads a pso­ri­a­sis as­set as their Dupix­ent ri­val heads to the FDA

Leo Phar­ma, a small, cen­tu­ry-old Dan­ish drug­mak­er, has spent the past few years tail­ing Sanofi on their fran­chise drug Dupix­ent, bet­ting that an an­ti­body they …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER